Bruxism
Introduction
Bruxism is defined as a repetitive jaw-muscle activity characterized by involuntary clenching or grinding of teeth, or bracing or thrusting of the mandible. [1] This condition can manifest during sleep, known as sleep bruxism (SB), or during wakefulness, referred to as awake bruxism (AB). [1] While considered a behavior in otherwise healthy individuals, bruxism can act as a significant risk factor or comorbidity for various clinical outcomes. [1]
Background
Epidemiological studies indicate that sleep bruxism affects approximately 6% to 8% of the adult population, while awake bruxism has a reported prevalence of around 30%. [1] Despite being distinct entities, SB and AB can co-occur in up to 20% of individuals, suggesting potential shared underlying etiologies. [1] The development of SB is influenced by a combination of psychological factors, including dissatisfaction, stress sensitivity, and anxiety. [2] Behavioral traits such as alcohol, tobacco, and caffeine use, alongside pharmacological treatments, particularly stimulants and psychoactive medications, are also implicated in inducing or exacerbating SB. [3] Furthermore, SB is closely associated with physiological conditions like sleep-disordered breathing, sleep apnea, and gastroesophageal reflux disease. [4]
Biological Basis
Research highlights a significant genetic component contributing to the onset and clinical presentation of bruxism. [3] A genome-wide association study (GWAS) identified a significant association at rs10193179, an intronic variant within the Myosin IIIB (MYO3B) gene. [1] This specific A-allele of rs10193179 functions as an expression quantitative trait locus (eQTL), leading to higher expression of the Sp5 Transcription Factor (SP5) across various tissues, including the artery and pituitary. [1] Studies involving SP5 mouse knockouts have shown increased grip strength and hyperactivity, which aligns with features observed in bruxism pathology. [1] Genetic analyses also reveal correlations between probable SB and conditions such as sleep apnea, pain, depression, clinical insomnia, and upper respiratory diseases, as well as the use of antidepressants and hypnotic/sedative medications. [1]
Clinical Relevance
The repetitive and often forceful jaw-muscle activity characteristic of bruxism can lead to substantial clinical consequences. These include chronic pain, temporomandibular disorders (TMD), and severe tooth wear. [1] The occlusal forces generated during sleep bruxism, in particular, can be considerably greater than those typically produced during normal mastication. [1] Consequently, bruxism is a critical consideration in dental treatment planning, especially for restorative dentists and prosthodontists, due to its direct impact on the choice and success of dental interventions. [1] Bruxism may also serve as a physiological mechanism, potentially helping to maintain airway patency or prevent gastric acid reflux, which explains its frequent co-occurrence with conditions like sleep apnea and gastroesophageal acid reflux. [4]
Social Importance
Bruxism affects a considerable portion of the global population, impacting daily functioning and quality of life through associated headaches and severe pain. [1] Understanding the underlying mechanisms and clinical correlates of bruxism is crucial for guiding clinical decision-making among physicians and dentists. [1] A comprehensive understanding of this condition facilitates improved management strategies, addressing not only bruxism itself but also its various comorbidities. [1] This comprehensive approach is vital given that bruxism is recognized as a trait that influences multiple aspects of an individual's overall health. [1]
Phenotype Definition and Measurement Challenges
The primary limitation stems from the definition and measurement of probable sleep bruxism (SB) within the study, which relied exclusively on International Classification of Diseases (ICD) codes F45.8 and G47.8 from electronic health records. [1] This code-based diagnosis system in Finland prevented the differentiation between sleep bruxism and awake bruxism (AB), meaning the analyzed phenotype likely represents a combination of both. [1] Consequently, the observed associations, such as those with musculoskeletal symptoms, might be partially attributable to concomitant AB, introducing heterogeneity that could not be directly quantified. [1] While earlier studies provided validation analyses for SB in population-based samples, this study did not perform separate validation with chart data, instead relying on these prior observations and clinical recommendations. [1] This approach necessitates a degree of caution in interpreting the exact match between diagnostic codes and the clinical reality of bruxism, potentially impacting the precision of the findings. [1]
Generalizability and Ancestry-Specific Findings
The genetic analysis was conducted using data from the FinnGen release R9, which consists of a large cohort predominantly of Finnish ancestry. [1] While this provides a robust sample size for genetic discovery, it inherently limits the direct generalizability of the findings, particularly the identified genetic associations, to more diverse populations. [1] Furthermore, the specific ICD-10 codes (F45.8 and G47.8) utilized for defining probable bruxism are from the Finnish national version and are explicitly noted as not being directly portable to other countries. [1] This means that replication efforts in different international cohorts would require careful consideration of local diagnostic coding practices or the use of standardized questionnaire data to ensure comparability of the bruxism phenotype. [1]
Methodological Constraints and Remaining Knowledge Gaps
The study's analysis of associations between probable SB and comorbidities primarily estimated lifetime risk using logistic regression, which does not allow for the inference of temporal or causal relationships. [1] Although attempts were made to perform Cox proportional hazards analysis to investigate whether comorbidities preceded or followed the SB diagnosis, the data did not meet the necessary statistical assumptions, thus preventing the incorporation of temporal insights. [1] This leaves an important knowledge gap regarding the chronological sequence of symptom development and diagnoses. [1] Moreover, despite the comprehensive nature of the genetic analysis, complex traits like bruxism often exhibit missing heritability, implying that a significant portion of genetic influence may still be unexplained by common variants, or involves intricate gene-environment interactions not fully elucidated. [1] This highlights the ongoing need for further research to fully understand the complete genetic architecture and environmental factors contributing to bruxism. [1]
Variants
The genetic variant rs10193179 is located within an intron of the MYO3B gene and has been significantly associated with probable sleep bruxism. [1] The MYO3B gene, or Myosin IIIB, encodes the Myosin-IIIb protein, which belongs to the larger myosin superfamily. Myosins are motor proteins essential for various cellular functions, including muscle contraction, cell division, and intracellular transport, by interacting with actin filaments and hydrolyzing ATP to generate mechanical force. [1] The presence of this intronic variant suggests it may influence the expression levels or splicing patterns of the MYO3B gene, thereby affecting the quantity or function of the Myosin-IIIb protein.
The Myosin-IIIb protein is particularly well-characterized for its role in mechanosensory processes, notably in the contexts of hearing and vision. It contributes to the delicate regulation of actin filament dynamics, which is crucial for cellular responses to mechanical stimuli. [1] Given that myosins are fundamental to muscle activity, the involvement of MYO3B in sleep bruxism points to a potential mechanism linking this gene to the involuntary jaw muscle contractions that define the condition. This class of myosins is also distinguished by an amino-terminal kinase domain, indicating a broader role in signaling pathways beyond direct mechanical force generation. [1]
Further research has revealed that rs10193179 acts as an expression quantitative trait locus (eQTL). [1] Specifically, the A-allele of rs10193179 is correlated with increased expression of the SP5 Transcription Factor gene in various tissues, including the artery and pituitary gland. The SP5 gene encodes a transcription factor, a protein that regulates the transcription of other genes, thereby influencing a wide array of cellular processes. Studies in SP5 mouse models have demonstrated phenotypes such as increased grip strength and hyperactivity, traits that resonate with the repetitive and forceful jaw movements observed in sleep bruxism. [1] This indirect effect of rs10193179 on SP5 expression suggests that SP5 may also be a significant contributor to the underlying pathology of sleep bruxism, operating within the genetic landscape surrounding the MYO3B locus.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs10193179 | MYO3B | bruxism |
Defining Bruxism: Core Concepts and Manifestations
Bruxism is precisely defined as a repetitive jaw-muscle activity characterized by actions such as clenching or grinding of teeth, or by bracing or thrusting of the mandible. [3] This activity can manifest in two distinct forms: sleep bruxism (SB), which occurs during sleep, and awake bruxism (AB), which occurs during wakefulness. [1] While considered separate entities, research indicates a co-occurrence in up to 20% of cases, suggesting potential shared etiological pathways. [1] In otherwise healthy individuals, bruxism is generally regarded as a behavior rather than a disorder; however, it can serve as a significant risk factor or comorbidity for various clinical outcomes, including dental damage, headaches, severe pain affecting daily functioning and sleep, and temporomandibular disorders. [1] The forces generated during SB, for instance, can substantially exceed normal occlusal forces of mastication, highlighting its considerable clinical implications for dental health and treatment planning. [5]
Classification Systems and Clinical Context
The primary classification of bruxism distinguishes between its occurrence during sleep (SB) and wakefulness (AB), recognizing them as distinct yet potentially overlapping phenomena. [1] Within broader medical classification systems, such as the International Classification of Diseases (ICD), 10th revision, bruxism is categorized under F45.8, designated as "Other Somatoform Disorders". [6] This ICD-10 code, alongside G47.8, is often utilized for diagnosing "probable sleep bruxism" in clinical and research settings, particularly in Finland where dentists frequently employ these codes. [1] However, current diagnostic systems, especially those based on electronic health record codes, often face limitations in precisely differentiating between AB and SB, which can impact the comprehensive understanding of comorbidities like myofascial pain. [1] The evolving understanding of bruxism also suggests a transition from a purely categorical view to one that might incorporate dimensional approaches, acknowledging its spectrum from a benign behavior to a significant clinical concern.
Nomenclature and Diagnostic Approaches
The terminology surrounding bruxism is largely standardized, utilizing "bruxism" as the overarching term, with specific modifiers for "sleep bruxism" (SB) and "awake bruxism" (AB) to denote its temporal occurrence. [1] Key associated concepts include "repetitive jaw-muscle activity," "clenching," "grinding," "bracing," and "thrusting of the mandible," which describe the characteristic physical manifestations. [3] Diagnostic and measurement criteria for bruxism vary, ranging from patient self-reports, which are common in large epidemiological studies, to more objective measures. [1] While questionnaire-based assessments provide important symptomatic insights, the reliance on ICD codes like F45.8 and G47.8 from electronic health records for "probable SB" introduces a need for validation to ensure diagnostic accuracy. [1] Researchers also explore quantitative studies of bite force during sleep and the assessment of tooth wear as potential discriminators and objective measurement approaches, contributing to a more precise clinical and research understanding of the condition. [5]
Phenotypic Presentation and Clinical Impact
Bruxism is characterized by repetitive jaw-muscle activity, which can manifest as clenching or grinding of teeth, or bracing and thrusting of the mandible. This activity can occur either during sleep, known as sleep bruxism (SB), or while awake, referred to as awake bruxism (AB). [1] While SB and AB are distinct entities, a co-occurrence rate of up to 20% has been observed, suggesting potential shared underlying etiologies. [1] The clinical impact of bruxism can be significant, ranging from tooth damage to the development of headaches and severe pain, which can disrupt both sleep and daily functioning. [1] The forces generated during sleep bruxism can be substantially greater than those involved in normal mastication, highlighting its potential for causing adverse effects. [1]
In otherwise healthy individuals, bruxism may be considered a behavior rather than a disorder. However, its presence can serve as a risk factor or comorbidity for other clinical outcomes, necessitating careful consideration in treatment planning. [1] The severity of bruxism and its associated symptoms can vary widely among individuals, contributing to a diverse range of clinical phenotypes. Understanding these patterns is crucial for recognizing when bruxism transitions from a benign behavior to a condition requiring intervention. [1]
Diagnostic Approaches and Measurement Considerations
The assessment of bruxism often involves a combination of subjective and objective measures. Historically, large epidemiological studies have frequently relied on self-reports to estimate prevalence and identify cases of both sleep and awake bruxism. [1] More objective diagnostic tools include home-recorded sleep-time masticatory muscle activity, which can provide quantifiable data on the intensity and frequency of jaw movements. [2] For sleep bruxism, polysomnography is utilized, especially when evaluating its relationship with other sleep disorders like obstructive sleep apnea. [7]
In clinical practice, bruxism is classified under the International Classification of Diseases (ICD-10) with codes such as F45.8 ("Other Somatoform Disorders") or G47.8. [1] However, using electronic health record (EHR) data for diagnosis requires validation to ensure that these codes accurately reflect a clinical diagnosis of bruxism. [1] A significant diagnostic challenge, particularly when relying on current ICD coding systems, is the inability to differentiate between sleep bruxism and awake bruxism, which can introduce heterogeneity in population-level analyses. [1]
Epidemiological Patterns and Associated Conditions
Bruxism exhibits considerable variability across different demographic groups and is frequently associated with a range of comorbidities. The prevalence of sleep bruxism is estimated to be between 6% and 8%, while awake bruxism has a reported prevalence of approximately 30% in adult populations. [1] Analysis of probable sleep bruxism cases indicates notable demographic patterns: affected individuals tend to be younger, with a mean age of 51.0-51.1 years, compared to those without bruxism (mean age 60.5-60.9 years). [1] Furthermore, there is a distinct sex difference, with a higher proportion of females (79.5-79.9%) diagnosed with probable sleep bruxism compared to males (20.1-20.5%). [1]
Bruxism is strongly correlated with several health conditions, including pain, migraine, sleep apnea, and insomnia. [1] Psychiatric comorbidities, such as depression, are also frequently observed. [1] Other associated conditions include gastroesophageal acid reflux, upper respiratory diseases, and temporomandibular disorders (TMD). [1] Psychological factors like dissatisfaction, stress sensitivity, and anxiety are suggested as underlying contributors to sleep bruxism, alongside the influence of genetic variation. [1] Additionally, certain legal psychoactive substances and medications, such as SSRIs, have been identified as potential risk factors. [3]
Genetic and Molecular Predisposition
Bruxism, particularly sleep bruxism (SB), has a significant genetic component, with studies indicating that underlying genetic variation contributes to its onset and clinical presentation. Research has estimated that genetic factors account for approximately half of the phenotypic variance in the liability to sleep-related bruxism in young adults. [3] A large-scale genome-wide association study identified a significant association at rs10193179, located intronic to the Myosin IIIB (MYO3B) gene. This specific A-allele of rs10193179 functions as an expression quantitative trait locus (eQTL), leading to higher expression of the Sp5 Transcription Factor (SP5) across various tissues, including artery and pituitary, suggesting a potential biological mechanism involving gene expression regulation in the pathology of bruxism. [1]
Psychosocial and Lifestyle Factors
Psychological and behavioral factors are strongly implicated in the etiology of sleep bruxism. Dissatisfaction, stress sensitivity, and anxiety are recognized psychological contributors, with self-reported bruxism frequently mirroring levels of anxiety and stress in adults. [2] Beyond psychological states, certain behavioral traits and lifestyle choices are also associated with an increased risk of SB. These include the use of legal psychoactive substances such as alcohol, tobacco, and caffeine, which can influence neurological pathways and sleep architecture, thereby potentially exacerbating or inducing bruxism activity. [8]
Associated Medical Conditions and Medications
Sleep bruxism is frequently observed in conjunction with various medical conditions and can be influenced by pharmacological treatments. It is closely related to physiological traits such as sleep-disordered breathing, including obstructive sleep apnea, and gastroesophageal reflux disease. [1] In these cases, bruxism may serve as a compensatory mechanism to maintain airway patency or prevent acid reflux into the airways. Furthermore, psychiatric conditions like depression and clinical insomnia show genetic correlations with probable sleep bruxism, pointing to shared underlying biological pathways. [1] Certain medications, particularly stimulants, psychoactive drugs, antidepressants, and hypnotic/sedatives, are known to induce or worsen existing SB, highlighting the role of pharmacological interventions as potential contributing factors. [9]
Comorbidities and Systemic Associations
Bruxism, particularly sleep bruxism (SB), is not merely an isolated dental issue but is extensively linked with a range of systemic health conditions and behavioral traits. Research indicates strong associations with psychiatric comorbidities such as depression, showing a significantly increased odds ratio (OR ~6.68-6.75). [1] This highlights the importance of a holistic patient assessment that considers mental health in individuals presenting with bruxism. [2]
Furthermore, SB is frequently observed alongside other sleep-related disorders and upper respiratory conditions. Studies reveal a notable association with sleep apnea (OR ~1.85-1.88) and upper respiratory diseases (OR ~2.05-2.09) [1] suggesting potential shared pathophysiological pathways, such as mechanisms to maintain airway patency or prevent gastric acid reflux. [1] Temporomandibular disorders (TMDs), characterized by pain in the jaw muscles and joints, are also closely associated with probable SB, indicating that many individuals with TMD complaints may have underlying SB. [1] Beyond medical conditions, behavioral factors like alcohol, tobacco, and caffeine use, along with certain pharmacological treatments (e.g., stimulants, psychoactive medications), are recognized to induce or exacerbate SB. [3]
Diagnostic Utility and Treatment Implications
The clinical relevance of bruxism is paramount for accurate diagnosis and effective treatment planning, particularly in dentistry. While bruxism is defined by repetitive jaw-muscle activity, its diagnosis in clinical practice, often relying on ICD-10 codes like F45.8 or G47.8, faces challenges in differentiating between sleep bruxism (SB) and awake bruxism (AB). [1] This diagnostic limitation underscores the need for more refined assessment tools to tailor interventions appropriately, as the prevalence and potential concomitant nature of AB could aggravate symptoms like musculoskeletal pain. [1]
The direct clinical implications of bruxism are most evident in the oral cavity, where the substantial forces generated during clenching or grinding can lead to significant tooth wear and impact the success and selection of dental treatments. [1] Therefore, a thorough understanding of a patient's bruxism status is critical for restorative dentists and prosthodontists to prevent dental damage and ensure long-term treatment outcomes. [2] Given its broad impact on health, managing probable SB is advised whenever possible to mitigate individual-level consequences. [1]
Genetic Risk Factors and Personalized Medicine
Genetic factors play a significant role in the predisposition and clinical presentation of sleep bruxism, offering avenues for risk stratification and the development of personalized medicine approaches. Large-scale genetic analyses have identified specific genetic loci, such as rs10193179 intronic to the MYO3B gene, as significantly associated with probable SB (OR = 1.08, P = 1.68 x 10^-8). [1] This genetic marker, where the A-allele is an expression quantitative trait locus (eQTL) for higher SP5 expression, suggests potential biological mechanisms involving muscle function and activity. [1]
Understanding these genetic underpinnings provides a valuable framework for identifying individuals at higher risk for developing SB or for experiencing more severe forms of the condition. [1] While still an emerging field, integrating genetic insights into clinical practice could eventually enable more precise risk assessment, guiding early prevention strategies and informing personalized treatment selections based on an individual's genetic profile and susceptibility to specific comorbidities, ultimately improving comprehensive management in the presence of bruxism and its associated conditions. [1]
Genetic and Mechanosensory Pathways
Genetic factors contribute to the underlying biological mechanisms of bruxism, influencing muscle activity and mechanosensory processing. A key genetic association has been identified at the MYO3B locus, where the intronic variant rs10193179 is linked to probable sleep bruxism. [1] The MYO3B gene encodes Myosin-IIIb, a protein involved in hearing and vision, and is crucial for responding to mechanosensory input. [1] Myosin-IIIb, like other myosins, is an ATPase activated by actin filaments and plays a significant role in muscle function. [10] This suggests that dysregulation in actin filament dynamics or muscle contraction pathways, potentially mediated by Myosin-IIIb's amino-terminal kinase domain [11] could contribute to the repetitive jaw muscle activity characteristic of bruxism.
Further investigation into the MYO3B region reveals that the A-allele of rs10193179 acts as an expression quantitative trait locus (eQTL) for higher expression of the SP5 Transcription Factor across various tissues, including artery and pituitary. [1] SP5 knockout studies in mice have shown associations with increased grip strength and hyperactivity. [1] This suggests that altered SP5 transcription factor regulation could influence neural pathways controlling motor activity or muscle strength, potentially contributing to the forceful clenching and grinding observed in bruxism. The interplay between MYO3B and SP5 highlights a complex regulatory mechanism where genetic variants impact gene expression, potentially leading to aberrant mechanosensory responses and muscle control.
Neurophysiological Regulation of Jaw Muscle Activity
Bruxism is defined by repetitive jaw-muscle activity, including clenching, grinding, bracing, or thrusting of the mandible. [1] This motor activity is driven by the intricate neurophysiological control of masticatory muscles. Myosin proteins, such as Myosin-IIIb, are essential components of muscle contraction, functioning as ATPases that hydrolyze ATP to generate force when activated by actin. [10] The energy metabolism required for sustained, forceful muscle contractions during bruxism would involve a high flux through ATP-generating metabolic pathways. Alterations in the regulation of these pathways or in the efficiency of myosin function could contribute to the intensity and duration of bruxism events.
Moreover, the occurrence of sleep bruxism is intertwined with sleep architecture, which can be altered by the condition. [12] This suggests that the central nervous system's control over motor patterns during sleep is dysregulated, leading to emergent properties of jaw muscle activity. The neural networks governing sleep-wake cycles and motor control pathways likely exhibit crosstalk, where disturbances in one system can influence the other. For instance, the repetitive jaw movements might reflect an imbalance in excitatory and inhibitory neural signals within the brainstem motor nuclei responsible for mastication, indicating a breakdown in hierarchical regulation that normally suppresses such activity during sleep.
Neurochemical and Psychological Modulators
Psychological factors play a significant role in the etiology of bruxism, with associations noted for dissatisfaction, stress sensitivity, and anxiety. [2] These psychological states can influence neurotransmitter systems, such as those involving serotonin, dopamine, and norepinephrine, which are critical for mood regulation, stress response, and motor control. Dysregulation within these signaling pathways, potentially involving altered receptor activation or intracellular signaling cascades in specific brain regions, could lower the threshold for jaw muscle activity. Furthermore, behavioral traits like alcohol, tobacco, and caffeine use, along with pharmacological treatments such as stimulants and psychoactive medications (including SSRIs), have been linked to inducing or exacerbating bruxism. [3] These substances and medications often modulate neurotransmitter activity, suggesting that their impact on signaling pathways contributes to the observed jaw muscle activity. The interplay of psychological stress and neurochemical imbalances likely creates a permissive environment for the manifestation of bruxism.
Systemic Interactions and Comorbidity Mechanisms
Bruxism does not exist in isolation but shows significant systems-level integration with various physiological and clinical traits, often presenting as a comorbidity. It is closely associated with sleep disordered breathing, including obstructive sleep apnea, and gastroesophageal reflux disease. [4] In some instances, bruxism may even function as a compensatory mechanism, potentially helping to keep airways open or prevent gastric acid from entering the airways. [1] This suggests complex pathway crosstalk where the body attempts to mitigate one physiological stressor through an altered motor behavior. The increased workload on jaw muscles caused by bruxism can also lead to pain and temporomandibular disorders (TMDs), as well as excessive tooth wear. [1] This highlights a disease-relevant mechanism where the primary manifestation of bruxism directly causes secondary conditions, with significant genetic correlations observed between probable sleep bruxism and pain diagnoses, TMD, migraine, and insomnia. [1] These integrated network interactions underscore the multifactorial nature of bruxism and its broad impact on health.
Prevalence, Demographics, and Large-Scale Cohort Findings
Population studies have illuminated the prevalence and demographic patterns of bruxism, a condition characterized by repetitive jaw-muscle activity such as clenching or grinding of teeth. [1] While sleep bruxism (SB) is estimated to affect 6% to 8% of adults, awake bruxism (AB) shows a higher reported prevalence of approximately 30% in large epidemiological studies, primarily based on self-reports. [1] The co-occurrence of SB and AB can be as high as 20%, suggesting potential shared underlying etiologies. [1] A comprehensive Finnish study utilizing data from the FinnGen release R9, encompassing 377,277 individuals with linked hospital and primary care records, identified probable SB in 12,297 participants. [1] This large-scale cohort revealed that individuals with probable SB were generally younger (mean age 51.0 years) compared to those without bruxism (mean age 60.9 years) and exhibited a lower proportion of females (20.1% in the SB group versus 44.9% in the no bruxism group). [1] The study leveraged extensive biobank resources across Finland, including the Finnish Red Cross Blood Service Biobank, Helsinki Biobank, and Auria Biobank, to provide robust population-level insights into the condition. [1]
Comorbidity Patterns and Clinical Associations
Large population cohorts have significantly advanced the understanding of bruxism's associations with various health conditions. The Finnish FinnGen study revealed strong epidemiological links between probable SB and several comorbidities. [1] Notably, probable SB was highly associated with temporomandibular disorders (TMD), demonstrating an odds ratio (OR) of 6.75, indicating a substantially increased likelihood of co-occurrence. [1] Significant associations were also found with sleep apnea (OR = 1.88) and upper respiratory diseases (OR = 2.05), suggesting that bruxism may be a mechanism to maintain airway patency or prevent gastric acid reflux. [1] Furthermore, the study reinforced previous observations linking probable SB to pain and migraine, insomnia, and psychiatric comorbidities such as depression and anxiety, along with the use of related medications like antidepressants and sleep aids [1] These findings from combined registry data and clinical epidemiology underscore that probable SB is a trait affecting multiple aspects of health, with implications for comprehensive patient management. [1]
Methodological Considerations and Population-Specific Effects
The robust findings from large-scale population studies, such as the FinnGen analysis, rely on advanced methodologies but also highlight critical limitations. This particular study employed an electronic health record (EHR)-based approach, defining probable SB through ICD-10 codes (F45.8 or G47.8) linked to extensive genetic data. [1] While this design allowed for an unprecedented sample size of Finnish ancestry individuals, it introduced challenges, including the inability to differentiate between sleep bruxism and awake bruxism within the current Finnish diagnostic coding system. [1] The reliance on code-based diagnoses without separate chart validation in the study, though informed by earlier observations, may contribute to heterogeneity. [1] Moreover, the study noted that the specific ICD codes used are not directly portable to other countries, necessitating careful consideration for cross-population comparisons and replication efforts. [1] The study also acknowledged that while it estimated lifetime risk using logistic regression, it could not establish temporal relationships between probable SB and its comorbidities due to data limitations for Cox proportional hazards analysis. [1]
Frequently Asked Questions About Bruxism
These questions address the most important and specific aspects of bruxism based on current genetic research.
1. My dad grinds his teeth; will I too?
There's a significant genetic component to bruxism, so if your dad grinds his teeth, you might have an increased predisposition. Research has identified specific genetic variants, like one in the MYO3B gene, that influence your risk. However, many other factors, like stress and lifestyle, also play a role, so it's not a guarantee.
2. Does stress make me clench my jaw?
Yes, stress is a major contributor to jaw clenching and teeth grinding. Psychological factors like anxiety and stress sensitivity are strongly linked to bruxism. While stress can trigger or worsen it, your underlying genetic makeup can make you more susceptible to developing bruxism in response to stress.
3. Why do I grind my teeth, but my friend doesn't?
Individual differences in genetics can explain why some people experience bruxism and others don't. A specific genetic variant, rs10193179, has been associated with a higher expression of the SP5 gene, which is linked to traits like increased grip strength observed in bruxism. This means your genetic profile might make you more prone than your friend.
4. Can a DNA test predict my bruxism risk?
Genetic studies have identified specific markers, such as the A-allele of rs10193179 in the MYO3B gene, that are associated with a higher risk of bruxism. This variant acts as an eQTL, influencing the expression of the SP5 gene. Knowing if you carry such variants could indicate a genetic predisposition.
5. Is my tired feeling linked to teeth grinding?
Yes, your teeth grinding, especially during sleep, is often correlated with other sleep disturbances and conditions. There are genetic links between probable sleep bruxism and conditions like clinical insomnia and sleep apnea, which can certainly contribute to feeling tired. Bruxism can even be a physiological response to maintain airway patency during sleep.
6. Can I overcome my genetic tendency to grind?
While genetics contribute significantly, they are not the sole determinant. Environmental and behavioral factors like stress management, avoiding stimulants (caffeine, alcohol), and certain medications also play a large role. Understanding your genetic predisposition can help you focus on managing these other factors more effectively to reduce your symptoms.
7. Does my coffee or wine make my bruxism worse?
Yes, behavioral traits like caffeine and alcohol consumption are known to induce or exacerbate bruxism. Your genetic makeup might make you more sensitive to these substances, increasing their impact on your jaw clenching or grinding. Limiting these can often help manage your symptoms.
8. My jaw hurts; is my anxiety causing it?
Anxiety and other psychological factors like dissatisfaction and stress sensitivity are strongly linked to bruxism, which can cause jaw pain. There's also a genetic correlation between probable sleep bruxism and conditions like depression. So, it's very possible your anxiety is contributing to your jaw pain through bruxism.
9. Is teeth grinding ever a good thing for me?
Surprisingly, bruxism may sometimes serve a physiological purpose. It's often associated with conditions like sleep apnea and gastroesophageal reflux disease, and some theories suggest it might help maintain an open airway or prevent acid reflux during sleep. Genetic analyses have shown correlations between bruxism and these conditions.
10. Will my kids inherit my teeth grinding?
Given the significant genetic component to bruxism, there is a chance your children could inherit a predisposition. Research indicates that genetic factors account for a substantial portion of the variability in bruxism. However, remember that environmental influences and lifestyle choices will also play a role in whether they develop the condition.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Strausz, T., et al. "Genetic analysis of probable sleep bruxism and its associations with clinical and behavioral traits." Sleep, 2023. PMID: 37140068.
[2] Manfredini, D., Ahlberg, J., Lobbezoo, F. "Bruxism definition: past, present, and future - What should a prosthodontist know?" J Prosthet Dent, vol. 128, no. 5, 2022, pp. 905–912.
[3] Rintakoski, K., Hublin, C., Lobbezoo, F., Rose, R. J., Kaprio, J. "Genetic factors account for half of the phenotypic variance in liability to sleep-related bruxism in young adults: a nationwide Finnish study."
[4] Hesselbacher, S., et al. "Self-reported sleep bruxism and nocturnal gastroesophageal reflux disease in patients with obstructive sleep apnea: relationship." J Oral Rehabil, 2014.
[5] Nishigawa, K., Bando, E., Nakano, M. "Quantitative study of bite force during sleep associated bruxism." J Oral Rehabil, vol. 28, no. 5, 2001, pp. 485–.
[6] Whitfield, W. "The Icd-10 classification of mental and behavioral-disorders - clinical descriptions and diagnostic guidelines." J R Soc Health, vol. 113, no. 2, 1993, pp. 103–103.
[7] Hosoya, H., Kitaura, H., Hashimoto, T., et al. "Relationship between sleep bruxism and sleep respiratory events in patients with obstructive sleep apnea syndrome." Sleep Breath, vol. 18, no. 4, 2014, pp. 837–842.
[8] Rintakoski, K., and J. Kaprio. "Legal psychoactive substances as risk factors for sleep-related bruxism: a nationwide finnish twin cohort study." Alcohol Alcohol, vol. 48, no. 4, 2013, pp. 487–494.
[9] de Baat, C., Verhoeff, M., Ahlberg, J., et al. "Medications and addictive substances potentially inducing or attenuating sleep bruxism."
[10] Pette, D., and R. S. Staron. "Myosin isoforms, muscle fiber types, and transitions." Microsc Res Techniq, vol. 50, no. 6, 2000, pp. 500–509.
[11] Dose, A. C., and B. Burnside. "A class III myosin expressed in the retina is a potential candidate for Bardet-Biedl syndrome." Genomics, vol. 64, no. 2, 2000, pp. 183-191.
[12] Palinkas, M., Semprini, M., Espir, J., et al. "Nocturnal sleep architecture is altered by sleep bruxism." Arch Oral Biol, vol. 81, 2017, pp. 56–60.